Sign up to save your podcasts
Or
Share Why ICIs Have Revolutionized Cancer Care
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Why ICIs Have Revolutionized Cancer Care
CME credits: 0.25
Valid until: 31-10-2023
Claim your CME credit at https://reachmd.com/programs/cme/why-icis-have-revolutionized-cancer-care/14456/
Immune checkpoint inhibitors, or ICIs, have improved the prognosis for patients with many different types of cancer. Drs. Forde and García-Foncillas outline current biomarkers and the importance of testing to optimize patient outcomes. Your patients will thank you for tuning in!
=
View all episodes
By ReachMD
4.3
33 ratings
CME credits: 0.25
Valid until: 31-10-2023
Claim your CME credit at https://reachmd.com/programs/cme/why-icis-have-revolutionized-cancer-care/14456/
Immune checkpoint inhibitors, or ICIs, have improved the prognosis for patients with many different types of cancer. Drs. Forde and García-Foncillas outline current biomarkers and the importance of testing to optimize patient outcomes. Your patients will thank you for tuning in!
=